Alpha-1-adrenergic receptor blockade modifies Insulin-regulated aminopeptidase (IRAP) activity in rat prostate and modulates oxytocin functions

Drug Metabolism Letters

Volumn 5, Issue 3, 2011, Pages 192-196

  Saníger, Marcela Arrazola ^a   Ramírez Expósito, María Jesús ^a   de la Chica, Susana ^a   Carrera González, María Pilar ^a   Mayas, María Dolores ^a   Martínez Martos, José Manuel ^a  

^a UNIVERSITY OF JAÉN   (Spain)

Author keywords

Adrenergic receptors; Doxazosin; Insulin regulated aminopeptidase; Oxytocin; Placental Leucyl aminopeptidase; Prostate; Wistar rat

Indexed keywords

AMINOPEPTIDASE; DOXAZOSIN; INSULIN REGULATED AMINOPEPTIDASE; OXYTOCIN; UNCLASSIFIED DRUG;

ALPHA 1 ADRENERGIC RECEPTOR BLOCKADE; ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; RAT;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ANIMALS; CYSTINYL AMINOPEPTIDASE; DOXAZOSIN; IMMUNOENZYME TECHNIQUES; MALE; MUSCLE CONTRACTION; OXYTOCIN; PROSTATE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1;

RATTUS; RATTUS NORVEGICUS;

EID: 80052696224     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231211796905035     Document Type: Article

References (32)

1. Ivell, R.; Kimura, T.; Muller, D.; Augustin, K.z.; Abend, N.; Bathgate, R.; Telgmann, R.; Balvers, M.; Tillmann, G.; Fuchs, A.R. The structure and regulation of the oxytocin receptor. Exp. Physiol., 2001, 86(2), 289-296.
2. Ivell, R.; Balvers, M.; Rust, W.; Bathgate, R.; Einspanier, A. Oxytocin and male reproductive function. Adv. Exp. Med. Biol., 1997, 424, 253-264.
3. Harris, G.C.; Nicholson, H.D. Stage-related differences in rat seminiferous tubule contractility in vitro and their response to oxytocin. J. Endocrinol., 1998, 157(2), 251-257.
4. Bodanszky, M.; Sharaf, H.; Roy, J.B.; Said, S.I. Contractile activity of vasotocin, oxytocin, and vasopressin on mammalian prostate. Eur. J. Pharmacol., 1992, 216(2), 311-313.
5. Morita, T.; Shibata, K.; Kikkawa, F.; Kajiyama, H.; Ino, K.; Mizutani, S. Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo. Int. J. Cancer, 2004, 109(4), 525-532.
6. Cassoni, P.; Sapino, A.; Fortunati, N.; Munaron, L.; Chini, B.; Bussolati, G. Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A. Int. J. Cancer, 1997, 72(2), 340-344.
7. Cassoni, P.; Sapino, A.; Stella, A.; Fortunati, N.; Bussolati, G. Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors. Int. J. Cancer, 1998, 77(5), 695-700.
8. Novak, J.F.; Judkins, M.B.; Chernin, M.I.; Cassoni, P.; Bussolati, G.; Nitche, J.A.; Nishimoto, S.K. A plasmin-derived hexapeptide from the carboxyl end of osteocalcin counteracts oxytocinmediated growth inhibition of osteosarcoma cells. Cancer Res., 2000, 60(13), 3470-3476.
9. Pequeux, C.; Breton, C.; Hendrick, J.C.; Hagelstein, M.T.; Martens, H.; Winkler, R.; Geenen, V.; Legros, J.J. Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through autocrine/paracrine signaling. Cancer Res., 2002, 62(16), 4623-4629.
10. Cassoni, P.; Sapino, A.; Deaglio, S.; Bussolati, B.; Volante, M.; Munaron, L.; Albini, A.; Torrisi, A.; Bussolati, G. Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrineimmunological cross-talk. Cancer Res., 2002, 62(8), 2406-2413.
11. Lucas, R. L; Salm, A.K. Astroglia proliferate in response to oxytocin and vasopressin. Brain Res., 1995, 681(1-2), 218-222.
12. Isaacs, J.T.; Coffey, D.S. Etiology and disease process of benign prostatic hyperplasia. The Prostate., 1989, 2, 33-50.
13. Madsen, F.A.; Bruskewitz, R.C. Benign prostatic hyperplasia: pathophysiology and pharmacological treatment. Curr. Opin. Nephrol. Hypertens., 1995, 4(5), 455-459.
14. Nicholson, H.D.; Jenkin, L. Oxytocin and prostatic function. Advances in experimental medicine and biology, 1995, 395, 529-538.
15. Farina-Lipari, E.; Lipari, D.; Bellafiore, M.; Anzalone, R.; Cappello, F.; Valentino, B. Presence of atrial natriuretic factor in normal and hyperplastic human prostate and its relationship with oxytocin localisation. Eur. J. Histochem., 2000, 47(2), 133-138.
16. King, K.J.; Nicholson, H.D.; Assinder, S.J. Effect of increasing ratio of estrogen: androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP. Prostate, 2006, 66(1), 105-114.
17. Assinder, S.J.; Johnson, C.; King, K.; Nicholson, H.D. Regulation of 5alpha-reductase isoforms by oxytocin in the rat ventral prostate. Endocrinology, 2004, 145(12), 5767-5773.
18. Kiss, A.; Mikkelsen, J.D. Oxytocin-anatomy and functional assignments: a minireview. Endocr. Regul., 2005, 39(3), 97-105.
19. Mottet, N.; Costa, P.; Bali, J.P. Autonomic nervous system and prostatic physiology. Specific features of the alpha-adrenergic system. Prog. Urol., 1999, 9(1), 26-36.
20. Toda, S.; Ando, H.; Nagasaka, T.; Tsukahara, S.; Nomura, M.; Kotani, Y.; Nomura, S.; Kikkawa, F.; Tsujimoto, M.; Mizutani, S. Existence of placental leucine aminopeptidase/oxytocinase/insulinregulated membrane aminopeptidase in human endometrial epithelial cells. J. Clin. Endocrinol. Metab., 2002, 87(3), 1384-1389.
21. Tsujimoto, M.; Mizutani, S.; Adachi, H.; Kimura, M.; Nakazato, H.; Tomoda, Y. Identification of human placental leucine aminopeptidase as oxytocinase. Arch. Biochem. Biophys. 1992, 292(2), 388-392.
22. Rogi, T.; Tsujimoto, M.; Nakazato, H.; Mizutani, S.; Tomoda, Y. Human placental leucine aminopeptidase/oxytocinase. A new member of type II membrane-spanning zinc metallopeptidase family. J. Biol. Chem., 1996, 271(1), 56-61.
23. Chung, T.D.; Yu, J.J.; Spiotto, M.T.; Bartkowski, M.; Simons, J.W. Characterization of the role of IL-6 in the progression of prostate cancer. Prostate, 1999, 38(3), 199-207.
24. Carrera, M.P.; Ramirez-Exposito, M.J.; Duenas, B.; Mayas, M.D.; Garcia, M.J.; De la Chica, S.; Cortes, P.; Ruiz-Sanjuan, M.; Martinez-Martos, J.M. Insulin-regulated aminopeptidase/placental leucil Aminopeptidase (IRAP/P-LAP) and angiotensin IV-forming activities are modified in serum of rats with breast cancer induced by N-methyl-nitrosourea. Anticancer Res. 2006, 26(2A), 1011-1014.
25. Cassoni, P.; Marrocco, T.; Sapino, A.; Allia, E.; Bussolati, G. Evidence of oxytocin/oxytocin receptor interplay in human prostate gland and carcinomas. Int. J. Oncol., 2004, 25(4), 899-904.
26. de la Chica-Rodriguez, S.; Cortes-Denia, P.; Ramirez-Exposito, M.J.; Arias de Saavedra, J.M.; Sanchez-Agesta, R.; Del Carmen Perez, M.; Martinez-Martos, J.M. In vivo administration of doxazosin in rats highly decreases serum circulating levels of testosterone through a mechanism involving the testicular renin-angiotensin system. Int. J. Androl., 2008, 31(3), 364-370.
27. Whittington, K.; Assinder, S.; Gould, M.; Nicholson, H. Oxytocin, oxytocin-associated neurophysin and the oxytocin receptor in the human prostate. Cell and tissue research, 2004, 318(2), 375-382.
28. Nicholson, H.D. Oxytocin: a paracrine regulator of prostatic function. Reviews of reproduction, 1996, 1(2), 69-72.
29. Plecas, B.; Popovic, A.; Jovovic, D.; Hristic, M. Mitotic activity and cell deletion in ventral prostate epithelium of intact and castrated oxytocin-treated rats. J. Endocrinol. Invest., 1992, 15(4), 249-253.
30. Popovic, A.; Jovovic, D.; Hristic, M.; Martinovic, J. The effect of anterior pituitary gonadotrophic function in male rats. Iugoslava Phisiol. Pharmacol. Acta, 1982, 18, 95-106.
31. Frayne, J.; Nicholson, H.D. Localization of oxytocin receptors in the human and macaque monkey male reproductive tracts: evidence for a physiological role of oxytocin in the male. Mol. Hum. Reprod., 1998, 4(6), 527-532.
32. Einspanier, A.; Ivell, R. Oxytocin and oxytocin receptor expression in reproductive tissues of the male marmoset monkey. Biol. Reprod., 1997, 56(2), 416-422.